TFEB also contributes to being a potential therapeutic target for non-alcoholic fatty liver disease via the beneficial effect in regulating lipolysis and lipophagy (Yu et al., 2020). Here, TFEB is linked to metabolic dysfunction-associated steatotic liver disease.